Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
about
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancerCisplatin versus carboplatin in association with third-generation drugs for advanced non-small cell lung cancerContrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer CellsRandomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study).Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials.Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancerPaclitaxel plus platinum or gemcitabine plus platinum in first-line treatment of advanced non-small-cell lung cancer: results from 6 randomized controlled trials.Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association grouSystemic therapies in metastatic non-small-cell lung cancer with emphasis on targeted therapies: the rational approach.Long noncoding RNAs expression patterns associated with chemo response to cisplatin based chemotherapy in lung squamous cell carcinoma patients.The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trialsReview of the treatment of metastatic non small cell lung carcinoma: A practical approachOxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancerAdjuvant chemotherapy for early stage non-small cell lung cancer.Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland.Effectiveness of palliative care for non-small cell lung cancer.Impact of Symptom Clusters on Quality of Life Outcomes in Patients from Japan with Advanced Nonsmall Cell Lung Cancers.Combination of radiotherapy and chemotherapy in locally advanced NSCLC.Afatinib treatment in advanced non-small cell lung cancer.Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.Treatment of non-small cell lung cancer (NSCLC).Curcumin and lung cancer--a review.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents.Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer.Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib.A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis.Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.Flex-rigid pleuroscopy under local anesthesia in patients with dry pleural dissemination on radiography.Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors.Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy
P2860
Q24200413-1153E9C7-C355-400E-8606-0572D7823959Q24235240-FEFAE2D1-E622-47A9-8CDB-620C7A94AB2BQ28550076-175CA6E4-2570-4C00-9DA3-827DB99C6B40Q33397163-0F9AF88D-2029-4FDA-A8A8-2928A0BC7BFFQ33399463-381D058B-3FB8-4B61-8E56-D3F3278B3498Q33401530-D1040A2E-7A32-46A7-B79E-F39B2BA2860CQ33404683-126C612D-BC51-46A9-90A4-034914991DA9Q33442591-F7B8BCED-34C6-44E0-A844-0D235EFAC96FQ33789357-81B1373E-F3AF-4985-9D39-C43C14C8978BQ34252809-51206729-A6DE-4686-92F6-97A68817F4A8Q34331575-3FE82DCA-A47D-4DE2-85CD-784EE22175FAQ34650404-BE23103E-24E3-4C67-B44C-8DDE19D438D3Q35113397-ED42CF2D-75D7-43B7-888F-E453DEC50D6DQ35858069-8E4E9AAB-DA8C-4780-9659-B95309454A53Q35934898-1C56323E-C10B-49BF-BA74-4DD06CD2D556Q35971726-FA156498-9D4A-4118-BF29-B0E141D79B7CQ36942514-0B09391D-B42D-4016-816E-3A1068000E41Q37288002-8EA6C8DA-AAA5-4A08-A6D7-1F3B3C49E10FQ37559448-6E669673-C752-4B7A-8129-EB579648823CQ37614572-EDF17B53-CA88-47EA-B2D6-CB89E989F6DCQ37645209-795EB91F-9438-4468-A02C-57AAF5118502Q38032176-B6BE5B96-9CFC-4E4F-9EBC-6BE8D5408C55Q38150348-DE9E32D6-732A-44C6-8BA2-B2245A093C0EQ38212780-29616CCD-FEEA-4D97-BECB-23409C6CFE95Q38742506-EE9566EE-1477-4BF1-A999-BD21F3BB7355Q38847914-46ADABCB-60D1-481A-884C-2F02E20DAEBAQ38848421-CBABCF15-8CEA-47B2-9FE8-116E2B7B07E3Q38906773-07082432-4830-4AD1-8A61-87F64BFA964BQ39404847-9B1355A4-E2FD-4DC8-9116-C6B906B6AD1AQ40961397-9C2547F4-4752-465C-A564-2464936184C5Q41809109-06FCAB9C-09FB-4DEB-9100-9FE59918FB41Q42651607-775C7E78-702D-41CB-9697-67E1FFF3B44BQ43128788-0240FA3B-2959-437F-9241-B3631364FCBAQ43991401-1D5250D8-6771-4AE7-AD02-BEC4B69297DAQ45122603-17C7D41D-DEA9-4526-8D7C-12F75B2237B2Q45126932-81BF5D33-DBD7-47FB-8FB8-F80D34CD5907Q47860659-3353B8A5-82DC-45B9-BA23-DF59A54916BBQ54918484-9752335C-7255-47B7-83AB-8EC88DB6A581Q57172945-DF5B2B44-38A7-48A5-9340-ACCB53CB8570
P2860
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Third-generation chemotherapy ...... lung cancer: a meta-analysis.
@en
type
label
Third-generation chemotherapy ...... lung cancer: a meta-analysis.
@en
prefLabel
Third-generation chemotherapy ...... lung cancer: a meta-analysis.
@en
P2093
P1476
Third-generation chemotherapy ...... lung cancer: a meta-analysis.
@en
P2093
Charles Poole
Daniel B Fried
Maria Q Baggstrom
Mark A Socinski
Thomas A Hensing
Thomas E Stinchcombe
P304
P356
10.1097/JTO.0B013E31814617A2
P577
2007-09-01T00:00:00Z